A large number of questions, though
, still remain open after the European Court of Justice’s rulings on the reimbursement of treatment costs incurred in another Member State, and so what we expect from the Commission is proposals, not only as
to how patients can have greater legal certainty, but also as to how the national health services can be protected from the potentially adv
erse effects of the ...[+++]internal market rules.